XTLB (XTL Biopharmaceuticals Ltd. American Depositary Shares) Stock Analysis - Community
XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) is a publicly traded Healthcare sector company. As of May 21, 2026, XTLB trades at $2.52 with a market cap of $6.39M and a P/E ratio of 0.00. XTLB moved -2.57% today. Year to date, XTLB is +1.34%; over the trailing twelve months it is -43.64%. Its 52-week range spans $2.12 to $10.28. Rallies surfaces XTLB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade XTLB?
Rallies community data for XTLB shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
EDELMAN JOSEPH sold 9.60M (~$1.47M) on Nov 19, 2008.
EDELMAN JOSEPH sold 24.68M (~$3.48M) on Nov 18, 2008.
EDELMAN JOSEPH sold 2.70M (~$412.02K) on Nov 18, 2008.
XTLB Analyst Consensus
XTLB analyst coverage data. Average price target: $0.00.
Common questions about XTLB
How does the Rallies community trade XTLB?
Rallies community data for XTLB shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for XTLB?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for XTLB when enough community data is available.
Is XTLB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XTLB. It does not provide personalized investment advice.